Convivia Inc., Raptor deal

RPTP acquired a clinical program targeting aldehyde dehydrogenase ( ALDH2) deficiency from Convivia for 200,000 RPTP shares worth $110,000 based on RPTP's close of $0.55 on Oct. 19, the last trading day before the deal was announced. Convivia is eligible for milestones to be paid in RPTP shares. ...